Biotech · Private company · Baltimore, MD, US

Oncosting LLC

Track this companyFree. Adds Oncosting LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

STING agonist-expressing BCG to enhance bladder cancer therapyFiscal year 2026 · $1MNIH RePORTER 1R44CA310037-01 · fetched Nov 12, 2026
BCG overexpressing a small molecule STING agonist as a vaccine for TBFiscal year 2026 · $986.9KNIH RePORTER 5R44AI181290-03 · fetched Nov 12, 2026
BCG overexpressing a small molecule STING agonist as a vaccine for TBFiscal year 2025 · $991.1KNIH RePORTER 4R44AI181290-02 · fetched Nov 12, 2026
BCG overexpressing a small molecule STING agonist as a vaccine for TBFiscal year 2024 · $270.2KNIH RePORTER 1R44AI181290-01A1 · fetched Nov 12, 2026